EXOC4 Blocking Peptide (N-term)
€363.00
In stock
SKU
AC-BP21329a
Background:
Component of the exocyst complex involved in the docking of exocytic vesicles with fusion sites on the plasma membrane.
Other Names:
Exocyst complex component 4, Exocyst complex component Sec8, EXOC4, KIAA1699, SEC8, SEC8L1
Target/Specificity:
The synthetic peptide sequence is selected from aa 239-253 of HUMAN EXOC4
Gene Name: EXOC4
Gene ID: 60412
Primary Accession: Q96A65
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Component of the exocyst complex involved in the docking of exocytic vesicles with fusion sites on the plasma membrane.
Other Names:
Exocyst complex component 4, Exocyst complex component Sec8, EXOC4, KIAA1699, SEC8, SEC8L1
Target/Specificity:
The synthetic peptide sequence is selected from aa 239-253 of HUMAN EXOC4
Gene Name: EXOC4
Gene ID: 60412
Primary Accession: Q96A65
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review